9,482 Shares in National Health Investors, Inc. $NHI Bought by Moody National Bank Trust Division

Moody National Bank Trust Division purchased a new stake in National Health Investors, Inc. (NYSE:NHIFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,482 shares of the real estate investment trust’s stock, valued at approximately $723,000.

Several other institutional investors and hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC bought a new position in shares of National Health Investors during the fourth quarter worth about $27,000. EverSource Wealth Advisors LLC boosted its position in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of National Health Investors during the 4th quarter worth approximately $33,000. Key Capital Management INC bought a new position in shares of National Health Investors during the 4th quarter worth approximately $47,000. Finally, Advisory Services Network LLC acquired a new stake in shares of National Health Investors in the third quarter valued at approximately $65,000. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Up 0.8%

Shares of NHI stock opened at $75.13 on Thursday. National Health Investors, Inc. has a 52-week low of $67.94 and a 52-week high of $91.38. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The stock has a market cap of $3.64 billion, a price-to-earnings ratio of 24.24, a PEG ratio of 3.35 and a beta of 0.51. The firm’s 50-day moving average is $75.09 and its 200-day moving average is $79.67.

Analyst Ratings Changes

A number of brokerages have recently commented on NHI. Zacks Research lowered shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. Wells Fargo & Company lowered their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a research note on Monday, June 1st. BMO Capital Markets cut their price target on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a research note on Wednesday, April 22nd. Finally, Weiss Ratings downgraded National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, National Health Investors presently has an average rating of “Moderate Buy” and an average price target of $83.86.

View Our Latest Report on NHI

Insider Buying and Selling

In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 890 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director owned 44,159 shares in the company, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO D. Eric Mendelsohn acquired 1,500 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the transaction, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is currently owned by insiders.

National Health Investors Company Profile

(Free Report)

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

Featured Articles

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.